Computer- and NMR-aided design of small-molecule inhibitors of the Hub1 protein

27 January 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Protein-protein interactions play a key role in cell homeostasis and physiological functions of the organisms. Consequently, their malfunction leads to diseases such as cancer, metastasis and neurodegeneration. The Hub1/Snu66 interaction is responsible for controlling alternative splicing through non-covalent binding to the HIND (Hub1-Interacting Domain) domain of the Snu66 spliceosomal protein. To better understand how Hub1 works in living organisms, we conducted a study to find small molecules that have an affinity for the Snu66 binding site of Hub1. The in silico investigation was based on global peptide modeling followed by high-resolution protein-peptide refinement. Docking analysis of nearly 200 molecules in the binding pocket of Hub1 is also described. Finally, Nuclear Magnetic Resonance fragment-based screening was used to confirm our findings.

Keywords

Protein-protein interactions
small-molecule inhibitors
protein-peptide docking
nuclear magnetic resonance
anti-cancer therapy

Supplementary materials

Title
Description
Actions
Title
Computer- and NMR-aided design of small-molecule inhibitors of the Hub1 protein
Description
Supplementory materials conteins, figures and tables additional to the main text
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.